KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) EBITDA (2016 - 2025)

Historic EBITDA for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $18.5 million.

  • Staar Surgical's EBITDA rose 22541.36% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.8 million, marking a year-over-year decrease of 47653.67%. This contributed to the annual value of -$12.6 million for FY2024, which is 14488.38% down from last year.
  • According to the latest figures from Q3 2025, Staar Surgical's EBITDA is $18.5 million, which was up 22541.36% from -$30.0 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's EBITDA registered a high of $18.5 million during Q3 2025, and its lowest value of -$57.4 million during Q1 2025.
  • In the last 5 years, Staar Surgical's EBITDA had a median value of $7.4 million in 2021 and averaged $1.1 million.
  • As far as peak fluctuations go, Staar Surgical's EBITDA soared by 110938.39% in 2021, and later tumbled by 241648.4% in 2025.
  • Staar Surgical's EBITDA (Quarter) stood at $7.4 million in 2021, then plummeted by 86.94% to $964000.0 in 2022, then surged by 979.36% to $10.4 million in 2023, then plummeted by 368.24% to -$27.9 million in 2024, then surged by 166.25% to $18.5 million in 2025.
  • Its EBITDA was $18.5 million in Q3 2025, compared to -$30.0 million in Q2 2025 and -$57.4 million in Q1 2025.